NovaBay Pharmaceuticals I...
0.70
-0.01 (-1.55%)
At close: Jan 15, 2025, 3:53 PM
0.68
-2.63%
After-hours Jan 15, 2025, 03:54 PM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10 FY09 FY08 FY07 FY06 FY05 FY04 FY03
Revenue 14.73M 14.40M 8.42M 9.93M 6.60M 12.51M 18.23M 11.90M 4.38M 1.05M 3.48M 6.95M 11.02M 9.75M 15.68M 6.72M 5.91M 1.53M n/a n/a n/a
Cost of Revenue 6.83M 6.62M 2.78M 3.97M 1.74M 1.50M 2.78M 2.46M 1.26M 486.00K 162.00K 8.00K n/a n/a n/a n/a n/a n/a n/a n/a n/a
Gross Profit 7.89M 7.78M 5.64M 5.96M 4.86M 11.01M 15.45M 9.43M 3.12M 568.00K 3.31M 6.94M 11.02M 9.75M 15.68M 6.72M 5.91M 1.53M n/a n/a n/a
Operating Income -5.00M -7.68M -8.86M -6.43M -9.40M -7.87M -7.31M -10.98M -21.01M -16.88M -15.49M -8.31M -4.32M -4.52M 2.74M -8.51M -5.88M -5.53M -3.57M -2.80M -953.00K
Interest Income n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Pretax Income -9.64M -10.61M -5.82M -11.03M -9.65M -6.54M -7.40M -13.15M -18.97M -15.19M -16.04M -7.03M -5.08M -4.26M 2.70M -8.11M -5.39M -5.29M -3.46M n/a -977.00K
Net Income -9.64M -16.27M -6.56M -11.04M -10.49M -6.54M -7.40M -13.15M -18.97M -15.19M -16.04M -7.03M -5.08M -4.31M 2.70M -8.11M -5.40M -5.29M -3.46M -2.80M -977.00K
Selling & General & Admin 12.83M 15.29M 14.46M 12.11M 14.08M 18.62M 22.35M 19.04M 18.09M 7.93M 6.34M 5.98M 5.43M 5.65M 5.61M 5.64M 4.37M 2.97M 1.62M n/a n/a
Research & Development 68.00K 174.00K 44.00K 285.00K 184.00K 259.00K 410.00K 1.37M 6.04M 9.51M 12.46M 9.28M 9.91M 8.62M 7.34M 9.60M 7.42M 4.09M 1.95M n/a 270.00K
Other Expenses n/a -276.00K -1.58M 605.00K -1.43M 19.00K 12.00K -68.00K -96.00K 22.00K 1K -155.00K n/a n/a n/a n/a n/a n/a n/a -2.80M n/a
Operating Expenses 12.90M 15.46M 14.51M 12.39M 14.26M 18.88M 22.76M 20.41M 24.13M 17.45M 18.80M 15.26M 15.34M 14.27M 12.94M 15.23M 11.79M 7.06M 3.57M -2.80M 953.00K
Interest Expense n/a n/a n/a n/a 1.05M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Selling & Marketing Expenses 6.50M 7.80M 7.22M 6.17M 8.77M 12.79M 13.71M 11.81M 10.52M 1.75M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses 19.73M 22.08M 17.28M 16.36M 16.00M 20.38M 25.54M 22.88M 25.39M 17.93M 18.96M 15.26M 15.34M 14.27M 12.94M 15.23M 11.79M 7.06M 3.57M -2.80M 953.00K
Income Tax n/a -3.81M -4.62M 5.00K 6.00K 4.00K 3.00K 2.00K 12.00K 2.00K 2.00K 2.00K 2.00K 50.00K 7.00K 2.00K 12.00K -240.00K -106.00K 2.80M n/a
Shares Outstanding (Basic) 120.43K 30.00K 31.64K 28.63K 16.27K 11.60K 12.51K n/a n/a n/a n/a 33.46K 29.45K 26.66K 25.60K 24.36K 10.26K 6.53K 5.54K 5.00K 4.62K
Shares Outstanding (Diluted) 120.43K 46.00K 35.63K 28.63K 17.67K 13.93K 12.51K n/a n/a n/a n/a 33.66K 29.45K 26.66K 26.42K 24.36K 10.26K 6.53K 5.54K 5.00K 4.62K
EPS (Basic) -138.65 -353.59 -184.09 -385.53 -593.63 -473.83 -591.81 n/a n/a n/a n/a -208.8 -172.64 -161.6 105.00 -333.14 -526.52 -809.37 -624.53 -560.46 -211.43
EPS (Diluted) -138.65 -353.59 -184.09 -385.53 -593.63 -564.17 -591.81 n/a n/a n/a n/a -210 -172.64 -161.6 105.00 -333.14 -526.52 -809.37 -624.53 -560.46 -211.43
EBITDA -4.80M -7.20M -8.74M -6.38M -9.34M -7.61M -7.22M -10.87M -20.97M -16.67M -15.17M -7.97M -3.90M -4.09M 3.15M -7.81M -5.21M -5.45M -3.42M -2.80M -929.00K
Depreciation & Amortization 203.00K 483.00K 119.00K 51.00K 65.00K 266.00K 95.00K 114.00K 164.00K 232.00K 314.00K 341.00K 425.00K 427.00K 373.00K 304.00K 183.00K 74.00K 48.00K n/a 24.00K

Create Price Alert on NBY

Your price alert will notify you when the stock price is above 0.70.

Add to Watchlist